As of December 2025, there is no approved fourth federal stimulus check. Former President Donald Trump has proposed a new round of payments, but this has not been approved by Congress. Arizona has ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

In mid-December 2025, an image (archived) circulated online purportedly showing U.S. President Donald Trump using a walker as a mobility aid. Keith Edwards, a Democratic political strategist, posted ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Terry Lane is a writer for Investopedia with 25 years of experience in journalism and communications. He covers personal finance, Congress, government regulations, and economics. Anna Moneymaker / ...

As some soldiers prepare to spend holidays deployed or away from their families, leaders across the service have been directed to “deliberately check in” on their soldiers every day, through December ...

Treasury Secretary Scott Bessent gave an update on President Donald Trump’s proposal to give $2,000 checks to Americans from tariff revenue. Bessent told Fox Business on Sunday that legislation would ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

There have never been more options for things to buy. Google is betting AI is how shoppers will make decisions. There have never been more options for things to buy. Google is betting AI is how ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...